NCT04823208View on ClinicalTrials.gov

A Study of LY3437943 in Japanese Participants With Type 2 Diabetes Mellitus (T2DM)

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

May 24, 2021

Primary Completion Date

June 23, 2022

Study Completion Date

June 23, 2022

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

LY3437943

Administered SC

DRUG

Placebo

Administered SC

Trial Locations (4)

565-0853

Medical Corporation Heishinkai OCROM Clinic, Suita-shi

192-0071

P-one clinic, Hachiōji

162-0053

Clinical Research Hospital Tokyo, Shinjuku-ku

232-0064

Yokohama Minoru Clinic, Yokohama

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY